000 01481 a2200433 4500
005 20250516044836.0
264 0 _c20120203
008 201202s 0 0 eng d
022 _a1872-9614
024 7 _a10.1016/j.nucmedbio.2011.03.007
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNye, Jonathon A
245 0 0 _aBiodistribution and human dosimetry of enantiomer-1 of the synthetic leucine analog anti-1-amino-2-fluorocyclopentyl-1-carboxylic acid.
_h[electronic resource]
260 _bNuclear medicine and biology
_cOct 2011
300 _a1035-41 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAnimals
650 0 4 _aBiological Transport
650 0 4 _aCycloleucine
_xanalogs & derivatives
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLeucine
_xanalogs & derivatives
650 0 4 _aMacaca mulatta
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aPositron-Emission Tomography
650 0 4 _aRadiation Dosage
650 0 4 _aRadiometry
650 0 4 _aStereoisomerism
700 1 _aJarkas, Nashwa
700 1 _aSchuster, David M
700 1 _aSavir-Baruch, Bital
700 1 _aVoll, Ronald J
700 1 _aCamp, Vernon M
700 1 _aGoodman, Mark M
773 0 _tNuclear medicine and biology
_gvol. 38
_gno. 7
_gp. 1035-41
856 4 0 _uhttps://doi.org/10.1016/j.nucmedbio.2011.03.007
_zAvailable from publisher's website
999 _c20993366
_d20993366